Hospira Logo (Cytarabine 01)
Cytarabine Injection, Solution
Product Images NDC 61703-319
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cytarabine (NDC 61703-319). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Cytarabine Structural Formula (Cytarabine 02)
Hospira Logo (Cytarabine 03)
Principal Display Panel (20 mL Vial Label)
Principal Display Panel (20 mL Vial Carton)
This text appears to contain product information for a medication called "Cytarabine Injection", which is a sterile solution used as a cytotoxic agent. It is intended for intravenous, intrathecal, and subcutaneous use and comes in a 120mL vial. Each mL contains 100mg of Cytarabine, USP and is free of preservatives. To adjust the pH to 7.7, sodium hydroxide and/or hydrochloric acid may be used. Dosage information can be found in the package insert, and the solution should be protected from light, discarded if unused, and stored at 20-25°C (68-77°F). The product is distributed by Hospira, Inc.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
